Medical Decisions, Estrogen and Aging

Cover
Springer Science & Business Media, 20.12.2007 - 178 Seiten
If you are a woman between the ages of 45 and 75 and are trying to decide whether to try, or stick with, hormone therapy (HT), or if you are a physician with patients fitting this description, this book is for you – unless you are looking for a simple answer. If you are looking for a simple answer, you can go to the web site of one of the companies that manufactures hormones or makes money by administering hormone therapy (e. g. , AntiAgingGroup. com), or you can go to the we bsite of an organization that advocates ‘natural’ aging (e. g. , the Inter National Organization to Reclaim Menopause; Inorm. org). Any impartial advisor, however, is going to admit that the answer isn’t at all clear-cut. Jay Schulkin, I believe the reader will find, is such an impartial advisor, and he is going to take you several steps beyond simply acknowledging the ambiguity; he’s going to educate you about the biology, history, sociology, business, and ethics of hormone replacement therapy. As a prominent scientist doing research on hormones, a medical researcher, an expert on decision making, he is the ideal guide to the intricacies of the topic. You might think that all of this sounds superfluous for making an informed decision: “Just the facts, please.
 

Was andere dazu sagen - Rezension schreiben

Es wurden keine Rezensionen gefunden.

Inhalt

ter
4
Autonomic Regulation Heart and Strokes 49
50
Cancers and Bone
69
Conclusion
85
Conclusion
102
6
121
Hormones and Resonable Expectations of Aging
125
graphy 137
154
Urheberrecht

Andere Ausgaben - Alle anzeigen

Häufige Begriffe und Wortgruppen

Beliebte Passagen

Seite 164 - Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
Seite 153 - JG ( 1994) Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects.
Seite 147 - B: A randomized, open, parallelgroup study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999; 180: 1072-1079.

Bibliografische Informationen